Cargando…
Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target pos...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980583/ https://www.ncbi.nlm.nih.gov/pubmed/33741015 http://dx.doi.org/10.1186/s13014-021-01782-w |
_version_ | 1783667457416757248 |
---|---|
author | Hill, Colin S. Han-Oh, Sarah Cheng, Zhi Wang, Ken Kang-Hsin Meyer, Jeffrey J. Herman, Joseph M. Narang, Amol K. |
author_facet | Hill, Colin S. Han-Oh, Sarah Cheng, Zhi Wang, Ken Kang-Hsin Meyer, Jeffrey J. Herman, Joseph M. Narang, Amol K. |
author_sort | Hill, Colin S. |
collection | PubMed |
description | PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target positioning, the magnitude of the shift as a result of inter- and intra-fraction variation may directly impact target coverage and dose to organs-at-risk. Herein, we characterize the variation patterns for PDAC patients treated at a high-volume institution with SBRT. METHODS: We reviewed 30 consecutive patients who received SBRT using active breathing coordination (ABC). Patients were aligned to bone and then subsequently shifted to fiducials. Inter-fraction and intra-fraction scans were reviewed to quantify the mean and maximum shift along each axis, and the shift magnitude. A linear regression model was conducted to investigate the relationship between the inter- and intra-fraction shifts. RESULTS: The mean inter-fraction shift in the LR, AP, and SI axes was 3.1 ± 1.8 mm, 2.9 ± 1.7 mm, and 3.5 ± 2.2 mm, respectively, and the mean vector shift was 6.4 ± 2.3 mm. The mean intra-fraction shift in the LR, AP, and SI directions were 2.0 ± 0.9 mm, 2.0 ± 1.3 mm, and 2.3 ± 1.4 mm, respectively, and the mean vector shift was 4.3 ± 1.8 mm. A linear regression model showed a significant relationship between the inter- and intra-fraction shift in the AP and SI axis and the shift magnitude. CONCLUSIONS: Clinically significant inter- and intra-fraction variation occurs during treatment of PDAC with SBRT even with a comprehensive motion management strategy that utilizes ABC. Future studies to investigate how these variations could lead to variation in the dose to the target and OAR should be investigated. Strategies to mitigate the dosimetric impact, including real time imaging and adaptive therapy, in select cases should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-021-01782-w. |
format | Online Article Text |
id | pubmed-7980583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79805832021-03-22 Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? Hill, Colin S. Han-Oh, Sarah Cheng, Zhi Wang, Ken Kang-Hsin Meyer, Jeffrey J. Herman, Joseph M. Narang, Amol K. Radiat Oncol Research PURPOSE: Variation in target positioning represents a challenge to set-up reproducibility and reliability of dose delivery with stereotactic body radiation therapy (SBRT) for pancreatic adenocarcinoma (PDAC). While on-board imaging for fiducial matching allows for daily shifts to optimize target positioning, the magnitude of the shift as a result of inter- and intra-fraction variation may directly impact target coverage and dose to organs-at-risk. Herein, we characterize the variation patterns for PDAC patients treated at a high-volume institution with SBRT. METHODS: We reviewed 30 consecutive patients who received SBRT using active breathing coordination (ABC). Patients were aligned to bone and then subsequently shifted to fiducials. Inter-fraction and intra-fraction scans were reviewed to quantify the mean and maximum shift along each axis, and the shift magnitude. A linear regression model was conducted to investigate the relationship between the inter- and intra-fraction shifts. RESULTS: The mean inter-fraction shift in the LR, AP, and SI axes was 3.1 ± 1.8 mm, 2.9 ± 1.7 mm, and 3.5 ± 2.2 mm, respectively, and the mean vector shift was 6.4 ± 2.3 mm. The mean intra-fraction shift in the LR, AP, and SI directions were 2.0 ± 0.9 mm, 2.0 ± 1.3 mm, and 2.3 ± 1.4 mm, respectively, and the mean vector shift was 4.3 ± 1.8 mm. A linear regression model showed a significant relationship between the inter- and intra-fraction shift in the AP and SI axis and the shift magnitude. CONCLUSIONS: Clinically significant inter- and intra-fraction variation occurs during treatment of PDAC with SBRT even with a comprehensive motion management strategy that utilizes ABC. Future studies to investigate how these variations could lead to variation in the dose to the target and OAR should be investigated. Strategies to mitigate the dosimetric impact, including real time imaging and adaptive therapy, in select cases should be considered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-021-01782-w. BioMed Central 2021-03-19 /pmc/articles/PMC7980583/ /pubmed/33741015 http://dx.doi.org/10.1186/s13014-021-01782-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hill, Colin S. Han-Oh, Sarah Cheng, Zhi Wang, Ken Kang-Hsin Meyer, Jeffrey J. Herman, Joseph M. Narang, Amol K. Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title | Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title_full | Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title_fullStr | Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title_full_unstemmed | Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title_short | Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy? |
title_sort | fiducial-based image-guided sbrt for pancreatic adenocarcinoma: does inter-and intra-fraction treatment variation warrant adaptive therapy? |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980583/ https://www.ncbi.nlm.nih.gov/pubmed/33741015 http://dx.doi.org/10.1186/s13014-021-01782-w |
work_keys_str_mv | AT hillcolins fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT hanohsarah fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT chengzhi fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT wangkenkanghsin fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT meyerjeffreyj fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT hermanjosephm fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy AT narangamolk fiducialbasedimageguidedsbrtforpancreaticadenocarcinomadoesinterandintrafractiontreatmentvariationwarrantadaptivetherapy |